Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug

NCT04810104 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Delays due to COVID

Conditions

Parkinson Disease
Mild Cognitive Impairment

Interventions

DRUG: AZD0328
DRUG: Placebo

Sponsor

King's College London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]